The UK SPIRIT 1 trial in newly diagnosed chronic myeloid leukaemia-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

The UK SPIRIT 1 trial in newly diagnosed chronic myeloid leukaemia

Published:2022-01-06 Issue:6 Volume:196 Page:
ISSN:0007-1048
Container-title:British Journal of Haematology
language:en
Short-container-title:Br J Haematol

Author:

Gallipoli Paolo¹^ORCID,Clark Richard E.²^ORCID,Byrne Jenny³,Apperley Jane F.⁴,Milojkovic Dragana⁴,Foroni Letizia⁴,Goldman John M.⁴,O’Brien Stephen⁵

Affiliation:

1. Centre for Haemato‐Oncology Barts Cancer Institute Queen Mary University of London London UK

2. Department of Molecular and Clinical Cancer Medicine University of Liverpool Liverpool UK

3. Department of Haematology Nottingham University Hospital Trust Nottingham UK

4. Centre for Haematology Imperial College London at Hammersmith Hospital London UK

5. Faculty of Medical Sciences Newcastle University Newcastle UK

Funder

Novartis

Publisher

Wiley

Subject

Hematology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/bjh.17961

Reference10 articles.

1. Imatinib plus Peginterferon Alfa-2a in Chronic Myeloid Leukemia

2. Combination of pegylated IFN-α2b with imatinib increases molecular response rates in patients with low- or intermediate-risk chronic myeloid leukemia

3. Tolerability-Adapted Imatinib 800 mg/d Versus 400 mg/d Versus 400 mg/d Plus Interferon-α in Newly Diagnosed Chronic Myeloid Leukemia

4. Immune modulation of minimal residual disease in early chronic phase chronic myelogenous leukemia

5. Combination of Dasatinib and Peg-Interferon Alpha 2b in Chronic Phase Chronic Myeloid Leukemia (CP-CML) First Line: Preliminary Results of a Phase II Trial, from the French Intergroup of CML (Fi-LMC)

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Engineering aspects of lipid-based delivery systems: In vivo gene delivery, safety criteria, and translation strategies;Biotechnology Advances;2024-05

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3